Definitive Contract 75N95024C00033
Award Date
9/15/24
Potential Completion Date
9/14/25
Potential Value
$300K
Federal Agency
National Institute on Drug Abuse
Awardee
Base Pair Biotechnologies Inc.
Ultimate Awardee
Not listed
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pearland, TX 77584, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $299,976.31 Firm Fixed Price definitive contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Guild Associates Inc. (doing business as Guild Biosciences), a small business manufacturer. The contract is for the development of point-of-care HIV viral load and drug adherence assays under the NIH's Small Business Innovation Research (SBIR) program. This work was solicited under SBIR Topic 001 of the anticipated PHS-2024-1...
This federal contract award, HHSN271201500631P, was made by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS), to Cisbio US, Inc., a foreign-owned for-profit company. The $84,700 firm-fixed-price purchase order contract is for the provision of assay kits and reagents, including those used to detect biomarkers related to disease research, as well as cell lines and collagen reagents. The contract has a total small business...
This is a base award to Scitech Strategies Inc., a small business, under the SBIR (Small Business Innovation Research) Program Phase I of the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The award is for the creation of an accurate model of the topical structure of PubMed and associated indicators. The contract has a firm fixed price of $225,000.00 for a period of performance from...
This is a $245,400 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to RPK Associates, LLC, a small business, for biological therapeutics product development subject matter expert consulting services. The contract supports the development of therapeutic biotechnology products (biologics) and includes option periods through November 16, 2025. The contract was awarded...
This is a $300,000.00 Firm Fixed Price Definitive Contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Vala Sciences Inc. to conduct Small Business Innovation Research (SBIR) Phase I research and development on the "Development of Novel In-Vitro and In-Vivo Models to Support NeuroHIV Research." The contract was set aside for small businesses and has an ultimate completion date of September 26, 2025. Vala Sciences...
This federal contract award is for a $299,999 Small Business Innovation Research (SBIR) Phase 1 contract issued by the National Institute of Mental Health (NIMH), which is part of the National Institutes of Health (NIH). The contract was awarded to Vitruvian Bio, LLC, a small, woman-owned, and disadvantaged business, to develop point-of-care assays for measuring HIV viral load and drug adherence. This contract is part of the NIH and Centers for Disease Control and Prevention (CDC) SBIR...
This is a $599,999 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Parabon NanoLabs, Inc., a small business. The objective of the contract is to develop a DNA-based HIV vaccine that will stimulate production of broadly neutralizing antibodies against the HIV-1 envelope protein trimer antigen. This is a Phase I Small Business Innovation Research (SBIR) contract under the...
This federal contract award, with an ID of HHSN271201500432P, was issued by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services (HHS), to Cisbio US, Inc., a foreign-owned for-profit company. The $128,330.00 firm-fixed-price purchase order contract was set aside for a small business. It was awarded on July 21, 2015, with an ultimate completion date of August 21, 2015. Based on Cisbio US, Inc.'s past federal contract experience, the contract...
This is a Cost Plus Fixed Fee contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Medavante, Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, valued at $625,055.25, is for research and development in physical science. The contract has a period of performance through September 16, 2011. This contract is a definitive contract, indicating it is a stand-alone award rather than being associated with a larger...
The U.S. National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, has awarded a $136,232.50 firm-fixed-price delivery order to Synectics For Management Decisions, Inc., a woman-owned small business. This delivery order was issued under the Chief Information Officer - Solutions and Partners 3, Small Business (CIO-SP3 SB) government-wide acquisition contract. The contract will provide web developer services to support NIDA's research programs...